Real-World Data And Budget Impact Analysis for Incobotulinum Toxin A and Onabotulinum Toxin A for Upper Limb Post-Stroke Spasticity At A Uk Centre

Botulinum toxins (BT) are a valuable treatment option for patients with post-stroke upper-limb spasticity (PS-ULS), which affects 33,000 patients in the UK. Xeomin (incobotulinum toxin A) and Botox (onabotulinum toxin A) are two BTs licensed for the treatment of PS-ULS. The treatment costs for Xeomin and Botox will depend on their real-world usage.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Robertson, P Datta, J Kusel, S Page, J Soon Source Type: research